Symbol
Incyte Corporation
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$95.17
Current price of the stock
$2M
Trading volume of the stock
$19.2B
Market capitalization of the company
Large Cap
Category of market capitalization
25.00%
Long-term growth mean estimate
3.88
Mean analyst rating
1.87%
Potential price appreciation based on analyst price targets
47.10%
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
0.01
Total debt to total equity ratio
3.20
Current ratio
92.75%
Gross profit margin
32.47%
Operating profit margin
32.47%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
35.31%
Pretax profit margin
31.05%
Net profit margin
9.12%
Measures profitability relative to shareholders' equity
9.69%
ROE excluding intangible assets
6.70%
Measures profitability relative to total assets
9.06%
Measures profitability relative to invested capital
0.22
Asset turnover ratio
1.19
Inventory turnover ratio
1.52
Receivables turnover ratio
59.03
Average number of days it takes to collect receivables
16.27
Measures valuation relative to earnings
15.03
P/E based on future earnings estimates
3.98
Measures valuation relative to sales
4.01
Measures valuation relative to book value
10.79
Measures valuation relative to operating cash flow
11.75
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2026 QuantStrategy.io, Arizet Labs, LLC